Embotelladora Andina S.A. (AKO-A) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 29, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Apr 1, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AKO-A SEC filings page.
Embotelladora Andina S.A. (AKO-A) reported $3.7B in revenue for fiscal year 2025, up 13.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (20-F and 6-K reports).
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Embotelladora Andina S.A.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Embotelladora Andina S.A.'s revenue grew 13.0% year-over-year to $3.7B, a solid pace of expansion. This earns a growth score of 68/100.
Embotelladora Andina S.A. has a moderate D/E ratio of 0.86. This balance of debt and equity financing earns a leverage score of 50/100.
Embotelladora Andina S.A.'s current ratio of 1.41 indicates adequate short-term liquidity, earning a score of 39/100. The company can meet its near-term obligations, though with limited headroom.
Embotelladora Andina S.A. has a free cash flow margin of 5.5%, earning a moderate score of 45/100. The company generates positive cash flow after capital investments, but with room for improvement.
Embotelladora Andina S.A. earns a strong 23.2% return on equity (ROE), meaning it generates $23 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 79/100. This is down from 23.8% the prior year.
Embotelladora Andina S.A. passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Embotelladora Andina S.A. generates $1.72 in operating cash flow ($506.1M OCF vs $294.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Embotelladora Andina S.A. generated $3.7B in revenue in fiscal year 2025. This represents an increase of 13.0% from the prior year.
Embotelladora Andina S.A. reported $294.9M in net income in fiscal year 2025. This represents an increase of 25.7% from the prior year.
Embotelladora Andina S.A. earned $0.31 per diluted share (EPS) in fiscal year 2025. This represents an increase of 25.7% from the prior year.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Embotelladora Andina S.A. generated $201.2M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 203.8% from the prior year.
Embotelladora Andina S.A. held $325.4M in cash against $1.1B in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Embotelladora Andina S.A.'s gross margin was 39.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.6 percentage points from the prior year.
Embotelladora Andina S.A.'s net profit margin was 8.0% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.8 percentage points from the prior year.
Embotelladora Andina S.A.'s ROE was 23.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.6 percentage points from the prior year.
Not reported for fiscal year 2025.
Capital Allocation
Embotelladora Andina S.A. invested $304.9M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 3.8% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
AKO-A Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.7B+13.0% | $3.2B+9.8% | $3.0B-4.2% | $3.1B+18.6% | $2.6B+9.2% | $2.4B-0.1% | $2.4B-0.6% | $2.4B-20.0% | $3.0B+12.8% | $2.7B+0.4% | $2.7B |
| Cost of Revenue | $2.2B+14.0% | $2.0B+8.3% | $1.8B-4.4% | $1.9B+17.1% | $1.6B+12.5% | $1.4B+2.1% | $1.4B+1.2% | $1.4B-19.9% | $1.7B+12.1% | $1.5B-1.0% | $1.6B |
| Gross Profit | $1.4B+11.3% | $1.3B+12.2% | $1.1B-3.9% | $1.2B+20.9% | $989.5M+4.1% | $950.1M-3.2% | $981.3M-3.2% | $1.0B-20.1% | $1.3B+13.8% | $1.1B+2.3% | $1.1B |
| Interest Expense | $5.0M-33.3% | $7.5M+46.3% | $5.1M+145.8% | $2.1M+560.6% | $314K-81.2% | $1.7M-7.1% | $1.8M-31.7% | $2.6M-70.9% | $9.0M+50.9% | $6.0M-47.9% | $11.5M |
| Income Tax | $120.9M-10.1% | $134.5M+38.3% | $97.2M-19.9% | $121.4M+123.5% | $54.3M-29.6% | $77.2M-6.0% | $82.1M+2.8% | $79.9M-5.1% | $84.2M+15.1% | $73.1M+24.2% | $58.9M |
| Net Income | $294.9M+25.7% | $234.5M+21.0% | $193.8M+32.7% | $146.0M-19.7% | $181.9M+6.1% | $171.5M-26.5% | $233.3M+68.0% | $138.9M-27.5% | $191.5M+41.2% | $135.7M+9.2% | $124.2M |
| EPS (Basic) | $0.31+25.7% | $0.25+21.0% | $0.20+32.7% | $0.15-19.7% | $0.19 | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS (Diluted) | $0.31+25.7% | $0.25+21.0% | $0.20+32.7% | $0.15-19.7% | $0.19 | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Diluted Shares (Avg).
AKO-A Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.8B+13.2% | $3.3B+0.4% | $3.3B-5.7% | $3.5B+1.1% | $3.5B+0.7% | $3.4B+7.2% | $3.2B+0.9% | $3.2B-7.4% | $3.4B+4.3% | $3.3B+5.5% | $3.1B |
| Current Assets | $1.1B+11.0% | $1.0B-8.0% | $1.1B-17.9% | $1.4B+16.0% | $1.2B+4.0% | $1.1B+56.5% | $716.4M+3.5% | $692.2M-12.0% | $786.7M-5.0% | $828.3M+7.0% | $773.9M |
| Cash & Equivalents | $325.4M+29.7% | $250.9M-26.9% | $343.3M+1.2% | $339.4M-5.2% | $357.9M-16.3% | $427.9M+102.2% | $211.6M+7.0% | $197.7M-10.7% | $221.5M+4.6% | $211.7M+15.9% | $182.6M |
| Accounts Receivable | $372.9M+11.2% | $335.5M-0.7% | $337.9M+3.8% | $325.5M+4.2% | $312.3M+14.5% | $272.8M+6.3% | $256.6M+2.5% | $250.3M-19.5% | $310.9M+8.9% | $285.5M | N/A |
| Goodwill | $150.5M+3.2% | $145.8M+5.6% | $138.0M-8.0% | $150.1M+8.1% | $138.8M+0.4% | $138.2M-15.1% | $162.8M-3.4% | $168.5M+10.8% | $152.1M-1.4% | $154.2M+13.8% | $135.5M |
| Total Liabilities | $2.4B+6.4% | $2.3B+1.5% | $2.3B-8.6% | $2.5B+14.1% | $2.2B-4.5% | $2.3B+19.0% | $1.9B-1.6% | $1.9B-8.2% | $2.1B+4.0% | $2.0B+5.9% | $1.9B |
| Current Liabilities | $801.6M-12.2% | $913.3M+16.6% | $783.3M-29.1% | $1.1B+77.3% | $622.8M+17.2% | $531.5M-3.9% | $552.8M-8.4% | $603.5M-13.3% | $696.2M+10.7% | $628.7M+16.9% | $538.0M |
| Non-Current Liabilities | $1.6B+18.6% | $1.4B-6.5% | $1.5B+7.9% | $1.4B-11.4% | $1.5B-11.2% | $1.7B+28.3% | $1.4B+1.4% | $1.3B-5.7% | $1.4B+1.1% | $1.4B+1.7% | $1.4B |
| Long-Term Debt | $1.1B+7.4% | $1.0B-6.2% | $1.1B+21.4% | $895.6M-25.9% | $1.2B-7.1% | $1.3B+34.3% | $969.6M-4.2% | $1.0B-4.4% | $1.1B+2.4% | $1.0B | N/A |
| Total Equity | $1.3B+29.1% | $984.2M-1.8% | $1.0B+0.7% | $995.1M-21.4% | $1.3B+11.0% | $1.1B-10.5% | $1.3B+5.0% | $1.2B-5.7% | $1.3B+4.6% | $1.2B+2.2% | $1.2B |
| Retained Earnings | $1.3B+42.8% | $898.8M+3.4% | $869.7M+4.3% | $834.2M-7.7% | $903.4M-1.8% | $919.8M+14.0% | $807.0M+21.5% | $664.4M+21.8% | $545.4M+23.1% | $443.1M | N/A |
Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Long-Term Investments.
AKO-A Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $506.1M+40.5% | $360.1M-13.2% | $414.7M-10.3% | $462.4M+28.9% | $358.8M-8.5% | $391.9M+14.4% | $342.7M+1.3% | $338.2M-16.1% | $403.0M+20.4% | $334.9M-10.6% | $374.5M |
| Capital Expenditures | $304.9M+3.8% | $293.9M+34.9% | $217.8M+0.3% | $217.2M+33.0% | $163.3M+35.3% | $120.7M-18.8% | $148.6M-14.6% | $174.0M-36.6% | $274.5M+42.8% | $192.1M+20.9% | $158.9M |
| Free Cash Flow | $201.2M+203.8% | $66.2M-66.4% | $196.8M-19.7% | $245.2M+25.4% | $195.5M-27.9% | $271.2M+39.8% | $194.0M+18.2% | $164.2M+27.7% | $128.6M-9.9% | $142.7M-33.8% | $215.6M |
| Investing Cash Flow | -$272.8Mn/m | -$292.2Mn/m | -$178.9Mn/m | -$99.1Mn/m | -$233.2Mn/m | -$314.8Mn/m | -$147.8Mn/m | -$169.7Mn/m | -$274.4Mn/m | -$170.7Mn/m | -$145.8M |
| Financing Cash Flow | -$178.2Mn/m | -$120.7Mn/m | -$211.5Mn/m | -$333.9Mn/m | -$135.6M-185.3% | $158.9Mn/m | -$170.7Mn/m | -$164.8Mn/m | -$127.3Mn/m | -$147.2Mn/m | -$139.3M |
| Dividends Paid | $215.0M+34.6% | $159.7M-14.9% | $187.5M-41.2% | $319.2M+155.2% | $125.1M-11.0% | $140.6M+21.3% | $115.9M-7.9% | $125.8M+3.3% | $121.9M+20.3% | $101.3M+31.9% | $76.8M |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Share Buybacks.
AKO-A Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 39.1%-0.6pp | 39.7%+0.8pp | 38.8%+0.1pp | 38.7%+0.8pp | 38.0%-1.8pp | 39.8%-1.3pp | 41.1%-1.1pp | 42.1%0.0pp | 42.2%+0.4pp | 41.8%+0.8pp | 41.0% |
| Net Margin | 8.0%+0.8pp | 7.2%+0.7pp | 6.6%+1.8pp | 4.7%-2.3pp | 7.0%-0.2pp | 7.2%-2.6pp | 9.8%+4.0pp | 5.8%-0.6pp | 6.4%+1.3pp | 5.1%+0.4pp | 4.7% |
| Return on Equity | 23.2%-0.6pp | 23.8%+4.5pp | 19.3%+4.7pp | 14.7%+0.3pp | 14.4%-0.7pp | 15.0%-3.3pp | 18.3%+6.9pp | 11.5%-3.4pp | 14.9%+3.9pp | 11.0%+0.7pp | 10.3% |
| Return on Assets | 7.9%+0.8pp | 7.1%+1.2pp | 5.9%+1.7pp | 4.2%-1.1pp | 5.3%+0.3pp | 5.0%-2.3pp | 7.3%+2.9pp | 4.4%-1.2pp | 5.6%+1.4pp | 4.1%+0.1pp | 4.0% |
| Current Ratio | 1.41+0.3x | 1.12-0.3x | 1.42+0.2x | 1.22-0.6x | 1.87-0.2x | 2.11+0.8x | 1.30+0.1x | 1.150.0x | 1.13-0.2x | 1.32-0.1x | 1.44 |
| Debt-to-Equity | 0.86-0.2x | 1.040.0x | 1.09+0.2x | 0.90-0.1x | 0.96-0.2x | 1.14+0.4x | 0.76-0.1x | 0.830.0x | 0.820.0x | 0.84 | N/A |
| Liabilities-to-Equity | 1.92-0.4x | 2.33+0.1x | 2.26-0.2x | 2.49+0.8x | 1.71-0.3x | 1.99+0.5x | 1.50-0.1x | 1.600.0x | 1.640.0x | 1.65+0.1x | 1.59 |
| Asset Turnover | 0.980.0x | 0.98+0.1x | 0.900.0x | 0.88+0.1x | 0.75+0.1x | 0.69-0.1x | 0.740.0x | 0.76-0.1x | 0.87+0.1x | 0.810.0x | 0.85 |
| FCF Margin | 5.5%+3.4pp | 2.0%-4.6pp | 6.7%-1.3pp | 7.9%+0.4pp | 7.5%-3.9pp | 11.4%+3.2pp | 8.1%+1.3pp | 6.8%+2.6pp | 4.3%-1.1pp | 5.4%-2.8pp | 8.1% |
Not reported in any period shown, so not listed: Operating Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Embotelladora Andina S.A. AKO-A | FY2025 | $3.7B | $294.9M | 8.0% | $3.8B | 59/100 |
| The Vita Coco Company, Inc. COCO | FY2025 | $609.8M | $71.3M | 11.7% | $3.3B | 72/100 |
| National Beverage Corp. FIZZ | FY2026 | $1.2B | $183.6M | 15.6% | $3.3B | 73/100 |
| Celsius Holdings, Inc. CELH | FY2025 | $2.5B | $108.0M | 4.3% | $7.4B | 58/100 |
| Primo Brands Corporation PRMB | FY2025 | $6.7B | $60.1M | 0.9% | $7.1B | 43/100 |
| Coca-Cola Consolidated, Inc. COKE | FY2025 | $7.2B | $570.6M | 7.9% | $14.0B | 55/100 |
Where Embotelladora Andina S.A. Ranks
Frequently Asked Questions
Embotelladora Andina S.A. (AKO-A) reported $3.7B in total revenue for fiscal year 2025. This represents a 13.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Embotelladora Andina S.A. (AKO-A) revenue grew by 13.0% year-over-year, from $3.2B to $3.7B in fiscal year 2025.
Yes, Embotelladora Andina S.A. (AKO-A) reported a net income of $294.9M in fiscal year 2025, with a net profit margin of 8.0%.
As of fiscal year 2025, Embotelladora Andina S.A. (AKO-A) had $325.4M in cash and equivalents against $1.1B in long-term debt.
Embotelladora Andina S.A. (AKO-A) had a gross margin of 39.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
Embotelladora Andina S.A. (AKO-A) had a net profit margin of 8.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Embotelladora Andina S.A. (AKO-A) has a return on equity of 23.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Embotelladora Andina S.A. (AKO-A) generated $201.2M in free cash flow during fiscal year 2025. This represents a 203.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Embotelladora Andina S.A. (AKO-A) generated $506.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
Embotelladora Andina S.A. (AKO-A) had $3.8B in total assets as of fiscal year 2025, including both current and long-term assets.
Embotelladora Andina S.A. (AKO-A) invested $304.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Embotelladora Andina S.A. (AKO-A) had a current ratio of 1.41 as of fiscal year 2025, which is considered adequate.
Embotelladora Andina S.A. (AKO-A) had a debt-to-equity ratio of 0.86 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Embotelladora Andina S.A. (AKO-A) had a liabilities-to-equity ratio of 1.92 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Embotelladora Andina S.A. (AKO-A) had a return on assets of 7.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Embotelladora Andina S.A. (AKO-A) trades at 12.9x earnings, its market capitalization divided by $294.9M net income, FY2025. The market capitalization is $3.8B as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Embotelladora Andina S.A. (AKO-A) trades at 1.0x sales, its market capitalization divided by $3.7B revenue, FY2025. The market capitalization is $3.8B as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Embotelladora Andina S.A. (AKO-A) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Embotelladora Andina S.A. (AKO-A) has an earnings quality ratio of 1.72x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Embotelladora Andina S.A. (AKO-A) scores 59 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.